🔎 Trials Near Me

Home › Gastrointestinal Stromal Tumors › Pennsylvania › Philadelphia

Gastrointestinal Stromal Tumors clinical trials in Philadelphia, PA

6 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

RecruitingPhase 3
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07218926

DESTINY-PANTUMOUR04

RecruitingObservational study
  • Research Site, Philadelphia
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

RecruitingPhase 2
  • Fox Chase Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07406633

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2
  • Thomas Jefferson University, Philadelphia
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

RecruitingPhase 1/2
  • Fox Chase Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05957367

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

RecruitingPhase 1
  • Thomas Jefferson University, Philadelphia
  • Temple University Health System, Philadelphia
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06655246

Gastrointestinal Stromal Tumors trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.